Buyout gives Advanco a bigger US footprint.
The looming November deadline for compliance with the Drug Supply Chain Security Act (DSCSA) represents a turning point of sorts: the majority of participants in the pharma supply chain—except for retail pharmacies—have contracts in place to implement the barcoding, data collection and transmission, and product verification requirements of that law. Thus, a lot of the business opportunity for new system sales by software vendors and systems integrators is already in place. However, there will still be a drawn-out slog in the US to get all systems functioning, and all the connectivity needed, for effective compliance. Additionally, pharmacy compliance is a bridge only some retailers have crossed.
One result of this is consolidation among solution providers, the latest being Advanco’s acquisition of Vantage Solutions. Advanco has an interesting pedigree: it is one of the vendors used by the Turkey Ministry of Health to help install a national track-and-trace serialization system in the 2008-2012 time frame—one of the first national implementations in the world. Its client base is now over 100, with 90% of its business in pharma. Vantage Solutions is a systems integrator and validation services provider, based in the US with a satellite office in Switzerland. Together, the two companies will be able to provide a “sophisticated suite of products and services across the full spectrum of the supply chain,” according to Alf Goebel, Advanco CEO.
Other recent consolidations in pharma track-and-trace include Dover Corp.’s buyout of Systech International (2020); NNIT’s purchase of Excellis Health Solutions (2020); and Antares Group’s rollup of rfXcel (2021) and Acsis (2022).
While there are still numerous opportunities in pharma supply chain work, Advanco (and others) are positioning themselves for traceability projects in other industries, such as food & beverage and cosmetics: “Other sectors are learning from the pharma industry and are looking to incorporate serialization as a key function,” says Goebel.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.